Verve Therapeutics Balance Sheet

Financials in millions JPY. Fiscal year is May - April.

Millions JPY. Fiscal year is May - Apr.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2016 - 2020
Period Ending	Apr '25 Apr 30, 2025	Apr '24 Apr 30, 2024	Apr '23 Apr 30, 2023	Apr '22 Apr 30, 2022	Apr '21 Apr 30, 2021	2016 - 2020
Cash & Equivalents	219	557	982	948	758	Upgrade
Cash & Short-Term Investments	219	557	982	948	758	Upgrade
Cash Growth	-60.68%	-43.28%	3.59%	25.07%	-41.74%	Upgrade
Receivables	262	262	270	221	231	Upgrade
Inventory	113	111	109	124	151	Upgrade
Prepaid Expenses	6	7	7	7	16	Upgrade
Other Current Assets	5	3	5	2	1	Upgrade
Total Current Assets	605	940	1,373	1,302	1,157	Upgrade
Property, Plant & Equipment	1,167	1,595	1,185	1,092	2,390	Upgrade
Long-Term Investments	312	293	262	254	256	Upgrade
Other Intangible Assets	-	7	3	-	40	Upgrade
Other Long-Term Assets	1	1	2	1	1	Upgrade
Total Assets	2,085	2,836	2,825	2,649	3,844	Upgrade
Accounts Payable	264	243	212	254	249	Upgrade
Accrued Expenses	93	98	98	107	106	Upgrade
Short-Term Debt	-	100	300	-	-	Upgrade
Current Portion of Long-Term Debt	7	42	57	-	-	Upgrade
Current Portion of Leases	44	42	-	-	-	Upgrade
Current Income Taxes Payable	162	140	186	296	140	Upgrade
Other Current Liabilities	43	52	57	52	54	Upgrade
Total Current Liabilities	613	717	910	709	549	Upgrade
Long-Term Debt	39	-	42	100	-	Upgrade
Long-Term Leases	257	301	-	-	-	Upgrade
Long-Term Deferred Tax Liabilities	3	1	-	-	-	Upgrade
Other Long-Term Liabilities	118	124	133	139	145	Upgrade
Total Liabilities	1,261	1,376	1,311	1,211	1,079	Upgrade
Common Stock	100	100	100	100	929	Upgrade
Additional Paid-In Capital	2,521	2,521	2,521	2,521	1,691	Upgrade
Retained Earnings	-1,831	-1,178	-1,092	-1,166	158	Upgrade
Treasury Stock	-18	-18	-18	-17	-17	Upgrade
Comprehensive Income & Other	52	35	3	-	4	Upgrade
Shareholders' Equity	824	1,460	1,514	1,438	2,765	Upgrade
Total Liabilities & Equity	2,085	2,836	2,825	2,649	3,844	Upgrade
Total Debt	347	485	399	100	-	Upgrade
Net Cash (Debt)	-128	72	583	848	758	Upgrade
Net Cash Growth	-	-87.65%	-31.25%	11.87%	-41.74%	Upgrade
Net Cash Per Share	-113.07	63.60	515.47	749.78	670.20	Upgrade
Filing Date Shares Outstanding	1.13	1.13	1.13	1.13	1.13	Upgrade
Total Common Shares Outstanding	1.13	1.13	1.13	1.13	1.13	Upgrade
Working Capital	-8	223	463	593	608	Upgrade
Book Value Per Share	727.88	1289.75	1338.64	1271.44	2444.74	Upgrade
Tangible Book Value	824	1,453	1,511	1,438	2,725	Upgrade
Tangible Book Value Per Share	727.88	1283.57	1335.99	1271.44	2409.37	Upgrade
Order Backlog	-	208	233	274	318	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.